Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

University of Waterloo

$33,000.00

Role of endogenous lipids in the regulation of biphasic insulin secretion.

EF 2020-21

Résumé
There are three sources of free fatty acids (FFA) 1) exogenously-derived FFAs, 2) endogenously-synthesized FFAs (de novo lipogenesis (DNL)) and 3) release from internal triglyceride stores. DNL occurs primarily in liver cells, however, many tissue types are able to produce limited amounts of lipid. The role of this small amount of DNL in these cell types is not completely understood. For example, insulin secreting cells of the pancreas express enzymes that lead to DNL in proportion to the amount of glucose exposure. This glucose driven DNL has been proposed to be important in generating metabolic signaling molecules important for regulating insulin exocytosis. It has also been suggested that glycerolipid (GL)/ FFA cycling from internal triglyceride stores may also play a role in the regulation of insulin release. Inhibition of this cycling suppresses FFA augmentation of glucose-stimulated insulin release. We have published results showing that the effects of manipulating four key enzymes (PC, CL, ACC and FAS) and three metabolic carriers (pyruvate carrier, citrate carrier and dicarboxylate carrier) that are involved in DNL lead to conflicting results for and against a role of DNL in regulating insulin exocytosis. We will continue to investigate the role of DNL in the regulation of glucose-stimulated insulin release using newly developed tools in the lab. We have also identified several glucose derived endogenous lipid species that may be critical for regulating biphasic insulin secretion using a metabolomics approach. A number of questions arise from these metabolomics studies for example what is the source of these glucose derived endogenous lipids (e.g. release from triglyceride (TG) stores or from DNL) and how might these lipids be involved in regulating biphasic insulin release. We will expand on these studies to further investigate the role of endogenous lipids in the regulation of biphasic insulin release. Hypothesis: Endogenous lipids generate signaling molecules that are critical to the metabolic regulation of biphasic insulin secretion. Experimental approach: We have identified several endogenous lipid species that may be critical for regulating biphasic insulin secretion using a metabolomics approach. We will use molecule cloning techniques, siRNAs and siRNA adenoviruses, metabolic assays, enzymatic assays, secretion assays, fluorescent imaging and metabolomics to measure metabolite profiles and metabolic fluxes in key endocrine models of fuel regulated secretion. The combination of these approaches will allow us to study all aspects of the metabolic regulation of biphasic insulin secretion by DNL. Novelty and significance: It is well known that exogenous lipids regulate insulin secretion but the role of endogenous is less well defined. These studies will provide invaluable insights towards understanding the unique role of lipids play in the regulation of exocytosis.
Programme
Discovery Grants Program - Individual
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
RGPIN-2016-04145
Name nom
Joseph, Jamie
Department département
School of Pharmacy
Organization id
33
Institution établissement
University of Waterloo
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2016
Award amount
33000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5107
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Cell secretion
Research subject fr
Sécrétions cellulaires
Installment
inst:5-6
Partie
2
Nb partie
6
Application title
Role of endogenous lipids in the regulation of biphasic insulin secretion.
Keyword
NSERC
Application summary
There are three sources of free fatty acids (FFA) 1) exogenously-derived FFAs, 2) endogenously-synthesized FFAs (de novo lipogenesis (DNL)) and 3) release from internal triglyceride stores. DNL occurs primarily in liver cells, however, many tissue types are able to produce limited amounts of lipid. The role of this small amount of DNL in these cell types is not completely understood. For example, insulin secreting cells of the pancreas express enzymes that lead to DNL in proportion to the amount of glucose exposure. This glucose driven DNL has been proposed to be important in generating metabolic signaling molecules important for regulating insulin exocytosis. It has also been suggested that glycerolipid (GL)/ FFA cycling from internal triglyceride stores may also play a role in the regulation of insulin release. Inhibition of this cycling suppresses FFA augmentation of glucose-stimulated insulin release. We have published results showing that the effects of manipulating four key enzymes (PC, CL, ACC and FAS) and three metabolic carriers (pyruvate carrier, citrate carrier and dicarboxylate carrier) that are involved in DNL lead to conflicting results for and against a role of DNL in regulating insulin exocytosis. We will continue to investigate the role of DNL in the regulation of glucose-stimulated insulin release using newly developed tools in the lab. We have also identified several glucose derived endogenous lipid species that may be critical for regulating biphasic insulin secretion using a metabolomics approach. A number of questions arise from these metabolomics studies for example what is the source of these glucose derived endogenous lipids (e.g. release from triglyceride (TG) stores or from DNL) and how might these lipids be involved in regulating biphasic insulin release. We will expand on these studies to further investigate the role of endogenous lipids in the regulation of biphasic insulin release. Hypothesis: Endogenous lipids generate signaling molecules that are critical to the metabolic regulation of biphasic insulin secretion. Experimental approach: We have identified several endogenous lipid species that may be critical for regulating biphasic insulin secretion using a metabolomics approach. We will use molecule cloning techniques, siRNAs and siRNA adenoviruses, metabolic assays, enzymatic assays, secretion assays, fluorescent imaging and metabolomics to measure metabolite profiles and metabolic fluxes in key endocrine models of fuel regulated secretion. The combination of these approaches will allow us to study all aspects of the metabolic regulation of biphasic insulin secretion by DNL. Novelty and significance: It is well known that exogenous lipids regulate insulin secretion but the role of endogenous is less well defined. These studies will provide invaluable insights towards understanding the unique role of lipids play in the regulation of exocytosis.